Latest News about ALT

Recent news which mentions ALT

< Previous 1 2 3 4 5 6 7 Next >

US Stocks Open Higher, Producer Prices Decline for 2nd Month

September 14, 2022

Altimmune Shares Fall Despite Fatty Liver Disease Study Meets Primary Goal

September 14, 2022

Altimmune Stock Is Tanking: What's Going On?

September 14, 2022

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

September 14, 2022

10 Health Care Stocks Whale Activity In Today's Session

September 13, 2022

Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday

August 15, 2022

Why Twin Vee Powercats Is Trading Higher By Around 90%, Here Are 84 Stocks Moving In Friday's Mid-Day Session

August 12, 2022

B. Riley Securities Maintains Buy Rating for Altimmune: Here's What You Need To Know

August 12, 2022

LegalZoom.com, Toast And Some Other Big Stocks Moving Higher On Friday

August 12, 2022

ALTIMMUNE INC (ALT) Q2 2022 Earnings Call Transcript

August 11, 2022

12 Health Care Stocks Moving In Wednesday's Intraday Session

August 03, 2022

7 Biotech Stocks to Buy for Q3

July 18, 2022

89 Biggest Movers From Friday

June 21, 2022

69 Biggest Movers From Yesterday

June 10, 2022

Piper Sandler Maintains Overweight Rating for Altimmune: Here's What You Need To Know

May 18, 2022

110 Biggest Movers From Friday

May 16, 2022

ALTIMMUNE INC (ALT) Q1 2022 Earnings Call Transcript

May 12, 2022

The Daily Biotech Pulse: Bristol Myers, BridgeBio Ink Oncology Pact, FDA Nod For Lava Therapeutics Blood Cancer Study And More

May 12, 2022

Altimmune: Q1 Earnings Insights

May 12, 2022

The Week Ahead In Biotech (May 8-14): Bausch Health Headlines Smid-Cap Earnings, Veru's Pre-EUA Meeting, Conference Presentations And More

May 09, 2022

Altimmune Earnings Perspective: Return On Capital Employed

March 16, 2022

ALTIMMUNE INC (ALT) Q4 2021 Earnings Call Transcript

March 15, 2022

Altimmune: Q4 Earnings Insights

March 15, 2022

The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial

March 15, 2022

Earnings Scheduled For March 14, 2022

March 14, 2022

The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings

March 13, 2022

Altimmune's Earnings Outlook

March 11, 2022

Are Intranasal Sprays The Next $36 Billion Trend in Vaccine Stocks?

February 08, 2022

Altimmune's Mid-Stage Pemvidutide Study Cleared By FDA For Obesity

January 31, 2022

12 Health Care Stocks Moving In Thursday's After-Market Session

December 30, 2021

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.